Delivery Order SPE2DR25D1053-SPE2DR26FT388
Award Date 10/28/25
Potential Completion Date 11/19/25
Potential Value $76K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $360,578.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on a firm fixed-price basis. The award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $32,694.46 under a firm fixed-price contract. The delivery order is non-set-aside and competitively awarded, with a completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $120,192.80 by the Defense Logistics Agency on September 18, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This firm fixed-price delivery order, which carries an ultimate completion date of October 9, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $53,535.55 for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is expected to be completed by November 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24,038.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on September 8, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $48,077.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $48,077.16. This is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $12,019.28 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a $48,077.16 delivery order to AmerisourceBergen Drug Corp for 4,569,852,928 units of Ocrevus 300 mg/10 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by November 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ocrevus (ocrelizumab) is a monoclonal antibody therapeutic used to treat multiple...
- The Defense Logistics Agency awarded a $240,385.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a competitive award with no set-aside designation, with a completion date of October 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor supporting...